Gene expression analyses in tumor tissues showed significantly increased mRNA levels of Cxcl10 and Cdkn1a in the combination treatment group (Fig. 7C), in line with the in vitro responses to CM272 in cultured PDAC cells. This evidence concerns the gene CXCL10 and neoplasm.